Naltrexone Terminated Phase 2 Trials for Obsessive Compulsive Disorder (OCD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00758966Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder